Couverture de Mushroom Talk

Mushroom Talk

Mushroom Talk

De : Alejandro Navia
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

There's a psychedelic renaissance taking place, and Mushroom Talk is here to cover it. We interview psychedelic therapists, practitioners, business investors, and everything in between, focusing on the application of psilocybin. A blend of science, investigation, memoir, and history for the curious and the skeptics. Deliciously trippy. Compellingly factual.

Hosted on Acast. See acast.com/privacy for more information.

Alejandro Navia
Economie Hygiène et vie saine Médecine alternative et complémentaire Sciences sociales
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Episode 4: Tim Schlidt
      May 27 2021

      On this episode of Mushroom Talk, we have Tim Schlidt joining us to chat about the role that venture capital plays in the psychedelic space. We dive deep into what he looks for in a founder and company when he is investing, and his story coming out of the psychedelic closet. One important note that we discuss are his thoughts on the corporatization of plant medicine, specifically the role of patents. Tim is a mover and shaker in the VC Psychedelic space bringing us a ton of knowledge, wisdom, and guidance on finance and psychedelics.


      About Tim:


      Years ago, co-founders Tim Schlidt, Daniel Goldberg, and Tony Eisenberg saw the enormous therapeutic potential psychedelic medicines posed. After years of researching and networking in the space, they co-founded Palo Santo in 2020 to focus on investing across this emerging ecosystem of psychedelic healthcare companies. As a former investment banker and private equity investor active in the life sciences and healthcare services sectors, Tim brings extensive experience evaluating healthcare deals and offers a unique perspective to the nascent sector of psychedelic-focused biopharma


      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      42 min
    • Mushroom Talk ep. 3 Tah & Kole Whitty
      May 14 2021

      On the third episode, we welcome Tah and Khole Whitty as we speak about the importance of integration with psychedelic medicine. They are some of the most intentional souls I've across in the psychedelic space. We speak about their experiences of overcoming drug overdose, helping others in emergency room settings, conscious partnership, creating safe containers for journeys, and the often overlooked yet the vital role that integration plays with psychedelic medicine. This is by far one of the most insightful conversations full of depth and wisdom we've had on mushroom talk.


      About Tah and Kole:


      Tah and Kole Whitty, a husband and wife team who married high above Machu Picchu. With over 25 years in emergency medicine, 17 years in trauma/addiction/keynote speaking, 15 years combined fitness/personal training/group fitness and 13 years shamanic traditions, we have seen a lot and learned a lot.


      What do we believe?


      Every "Body" has a unique language that holds the key to their Freedom and our job is to help you identify what your body is trying to tell you.

      The physical manifestation of subconscious thought patterns and stress coupled with the repression of emotion plays a huge roll in physical health.

      For more info check out our website tahkole.com

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      47 min
    • Mushroom Talk ep 2. Greg Kubin
      May 6 2021

      Welcome back to Mushroom Talk! On our second episode, I am speaking with Greg Kubin. How I met Greg, is a funny and awesome story rooted in the power of the internet and more accurately, the power of the DM. Greg’s goal is to help the psychedelic medicine movement succeed in multiple ways. He hosts the Business Trip podcast and co-leads PsyMed Ventures, a syndicate investing in psychedelic medicine.


      In this episode, we chat about the current investment environment, what Greg thinks psychedelics will look like in 5 years, his story about getting involved in the space, trends in the market, leadership, and much more.


      You can find Greg on Twitter: https://twitter.com/kubeans



      Please hit subscribe and leave us a review

      Hosted on Acast. See acast.com/privacy for more information.

      Afficher plus Afficher moins
      40 min
    Aucun commentaire pour le moment